Evidence map›Paper›PMID 32290603›Full record

ArticleMolecules (Basel, Switzerland)2020

Byoung Ok Cho, Denis Nchang Che, Ji-Su Kim, Jang Hoon Kim, Jae Young Shin, Hyun Ju Kang, Seon Il Jang

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Kushenol C fromHeliyon · 2023
    Article
  5. Review
  6. Review
  7. Sophoraflavanone G fromInternational journal of molecular sciences · 2022
    Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Byoung Ok ChoResearch Institute, Ato Q&A Co., LTD, Jeonju-si, Jeollabuk-do 54840, Korea.ORCID 0000-0001-8272-2282
Denis Nchang CheDepartment of Health Management, Jeonju University, Jeonju-si, Jeollabuk-do 55069, Korea.ORCID 0000-0003-2379-3405
Ji-Su KimDepartment of Health Management, Jeonju University, Jeonju-si, Jeollabuk-do 55069, Korea.
Jang Hoon KimAdvanced Radiation Technology Institute, Korea Atomic Energy Research Institute, Jeongeup, Jeollabuk-do 56212, Korea.ORCID 0000-0002-4496-5555
Jae Young ShinResearch Institute, Ato Q&A Co., LTD, Jeonju-si, Jeollabuk-do 54840, Korea.
Hyun Ju KangResearch Institute, Ato Q&A Co., LTD, Jeonju-si, Jeollabuk-do 54840, Korea.
Seon Il JangResearch Institute, Ato Q&A Co., LTD, Jeonju-si, Jeollabuk-do 54840, Korea.ORCID 0000-0001-6259-5124
Jeonju University · KRKorea Atomic Energy Research Institute · KR

Funding

National Research Foundation of Korea(NRF) grant funded by the Korea government(MSIT) NRF-2018R1D1A1B07050960
6 · The paper itself

Abstract

Kushenol C (KC) is a prenylated flavonoid isolated from the roots of

Indexed as

AnimalsAnti-Inflammatory AgentsAntioxidantsCatalaseCell LineFlavonoidsGlutathioneHaCaT CellsHumansLipopolysaccharidesMacrophagesMiceOxidative StressPlant ExtractsPlant RootsRAW 264.7 CellsAnti-Inflammatory AgentsAntioxidantsCatalaseFlavonoidsGlutathioneLipopolysaccharidesPlant ExtractsReactive Oxygen SpeciesSuperoxide Dismutasetert-Butylhydroperoxideanti-inflammationanti-oxidative stresskushenol CSophora flavescens

Identifiers

PMID32290603
PMCPMC7221590
OpenAlexW3015573318

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.